Every Form 4 that Clarus Corporation (CLAR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CLAR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLAR filings page.
Clarus Corp director Werner Roger received a grant of stock options covering 20,000 shares of common stock. These options have an exercise price of $3.11 per share and were awarded at no cost as a compensation-related grant. They were issued under Clarus’ Amended and Restated 2015 Stock Incentive Plan and will vest in four equal installments of 5,000 shares each on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, if service-based conditions are met. Following this grant, Roger holds 20,000 stock options directly, which are scheduled to expire on May 28, 2036 if not exercised.
Clarus Corp director Nicolas Sokolow received a grant of stock options covering 20,000 shares of common stock. The options have an exercise price of $3.11 per share and expire on May 28, 2036. They were granted under Clarus’ Amended and Restated 2015 Stock Incentive Plan.
The award vests in four equal installments of 5,000 options on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. Following this grant, Sokolow holds options to purchase 20,000 shares directly. This is a compensation-related grant rather than an open-market purchase or sale.
Clarus Corp director Susan Ottmann received a grant of stock options covering 20,000 shares of common stock. These options have an exercise price of $3.11 per share and expire on May 28, 2036. The grant was made under the company’s Amended and Restated 2015 Stock Incentive Plan.
The options vest in four equal installments of 5,000 shares each, becoming exercisable on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. Following this grant, Ottmann holds 20,000 stock options directly.
Clarus Corp director Mark Besca received a grant of stock options covering 20,000 shares of common stock. The options were awarded at an exercise price of $3.11 per share and were granted at no upfront cost. They expire on May 28, 2036 and were issued under the company’s Amended and Restated 2015 Stock Incentive Plan.
According to the vesting schedule, options for 5,000 shares will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. After this grant, Besca holds options to purchase 20,000 shares directly.
Clarus Corp Chief Financial Officer Michael J. Yates exercised a restricted stock award to acquire 25,000 shares of Common Stock on March 11, 2026. This transaction reflects the conversion of previously granted restricted stock under the company’s 2015 Stock Incentive Plan, rather than an open‑market purchase or sale.
Following the exercise, Yates directly holds 65,000 shares of Clarus Common Stock. The derivative award of 50,000 restricted shares had been granted earlier, with all shares vesting and becoming non‑forfeitable on March 11, 2025 and March 11, 2026, as described in the filing footnote.